{"id":"https://openalex.org/W3042016983","doi":"https://doi.org/10.1016/s2055-6640(20)30194-1","title":"In vitro demonstration of a potential role for STING agonist in HIV cure","display_name":"In vitro demonstration of a potential role for STING agonist in HIV cure","publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W3042016983","doi":"https://doi.org/10.1016/s2055-6640(20)30194-1","mag":"3042016983"},"language":"en","primary_location":{"id":"doi:10.1016/s2055-6640(20)30194-1","doi":"https://doi.org/10.1016/s2055-6640(20)30194-1","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)30194-1","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2055664020301941/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2055664020301941/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017746622","display_name":"A. Alicia Koblansky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Koblansky","raw_affiliation_strings":["UNC HIV Cure Center, Chapel Hill, USA","ViiV Healthcare, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC HIV Cure Center, Chapel Hill, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"ViiV Healthcare, Chapel Hill, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Raines","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Raines","raw_affiliation_strings":["UNC HIV Cure Center, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC HIV Cure Center, Chapel Hill, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003854063","display_name":"James Schawalder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Schawalder","raw_affiliation_strings":["ViiV Healthcare, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ViiV Healthcare, Chapel Hill, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064769935","display_name":"David M. Irlbeck","orcid":"https://orcid.org/0000-0002-8852-9261","observed_orcids":["https://orcid.org/0000-0002-8852-9261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Irlbeck","raw_affiliation_strings":["ViiV Healthcare, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ViiV Healthcare, Chapel Hill, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067293400","display_name":"Cristin M. Galardi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Galardi","raw_affiliation_strings":["ViiV Healthcare, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ViiV Healthcare, Chapel Hill, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058210027","display_name":"Jessica H. Brehm","orcid":"https://orcid.org/0000-0002-4589-279X","observed_orcids":["https://orcid.org/0000-0002-4589-279X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Brehm","raw_affiliation_strings":["ViiV Healthcare, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ViiV Healthcare, Chapel Hill, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038365114","display_name":"Joshi M. Ramanjulu","orcid":"https://orcid.org/0000-0003-3471-651X","observed_orcids":["https://orcid.org/0000-0003-3471-651X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Ramanjulu","raw_affiliation_strings":["GlaxoSmithKline, Upper Providence, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Providence, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008716404","display_name":"David M. Margolis","orcid":"https://orcid.org/0000-0001-5714-0002","observed_orcids":["https://orcid.org/0000-0001-5714-0002"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Margolis","raw_affiliation_strings":["UNC HIV Cure Center, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC HIV Cure Center, Chapel Hill, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063359656","display_name":"Heather M. Madsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Madsen","raw_affiliation_strings":["ViiV Healthcare, Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ViiV Healthcare, Chapel Hill, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22703412,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":null,"first_page":"45","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sting-agonist","display_name":"STING agonist","score":0.8949999809265137},{"id":"https://openalex.org/keywords/hiv-cure","display_name":"HIV cure","score":0.9950000047683716},{"id":"https://openalex.org/keywords/filgotinib","display_name":"filgotinib","score":0.9559999704360962},{"id":"https://openalex.org/keywords/jak1-inhibitor","display_name":"JAK1 inhibitor","score":0.9789999723434448},{"id":"https://openalex.org/keywords/clonal-expansion","display_name":"clonal expansion","score":0.8209999799728394},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9269999861717224},{"id":"https://openalex.org/keywords/intron-retention","display_name":"intron retention","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C2779300339","wikidata":"https://www.wikidata.org/wiki/Q7617409","display_name":"Sting","level":2,"score":0.8036587834358215},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5911086201667786},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5807730555534363},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4821305274963379},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3722032308578491},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32542532682418823},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2836914658546448},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1459154188632965},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12345224618911743},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0681624710559845},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.060902804136276245},{"id":"https://openalex.org/C146978453","wikidata":"https://www.wikidata.org/wiki/Q3798668","display_name":"Aerospace engineering","level":1,"score":0.04398500919342041}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/s2055-6640(20)30194-1","doi":"https://doi.org/10.1016/s2055-6640(20)30194-1","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)30194-1","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2055664020301941/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:3ddfe35b0b954da88132cb8abb49eda8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3ddfe35b0b954da88132cb8abb49eda8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Virus Eradication, Vol 5, Iss , Pp 45- (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/s2055-6640(20)30194-1","doi":"https://doi.org/10.1016/s2055-6640(20)30194-1","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)30194-1","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2055664020301941/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6100000143051147,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3042016983.pdf","grobid_xml":"https://content.openalex.org/works/W3042016983.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3041297558","https://openalex.org/W3038019102","https://openalex.org/W3024526747","https://openalex.org/W3199679122","https://openalex.org/W2368973079","https://openalex.org/W1974855063","https://openalex.org/W7006577982","https://openalex.org/W2120048927","https://openalex.org/W2133265651","https://openalex.org/W2099663930"],"abstract_inverted_index":{"1-58":[0],"45":[1],"we":[2,21,56,77],"examined":[3,57,78],"the":[4,10,47,58,66,72,79,96,140,151],"host":[5,127,159],"gene":[6,27,128,160],"RNA":[7,123,133],"landscape":[8,61],"at":[9],"integration":[11],"site.Fourth,":[12],"to":[13,45,64],"examine":[14,46,65],"which":[15,120,182],"cellular":[16],"pathways":[17],"mediates":[18],"HIV-1":[19,50,102,111,122],"suppression,":[20],"performed":[22],"transcriptome":[23],"analysis":[24,29],"and":[25,36,109],"differential":[26],"expression":[28],"in":[30,37],"HIV-1-GFP":[31],"reporter":[32],"cell":[33],"line":[34],"models":[35],"CD4":[38,90],"+":[39,91],"T":[40,92],"cells":[41,93,99,145,169],"from":[42],"HIV-1-infected":[43,75,89,144,168,187],"individuals.Fifth,":[44],"effect":[48,80],"of":[49,68,74,81,88,98,132,143,153,156,167,179,186],"suppressing":[51,112,172],"agents":[52,70,83,173,181],"on":[53,71,84],"transcriptional":[54],"landscape,":[55],"intron":[59],"retention":[60],"using":[62],"IRFinder.Finally,":[63],"impact":[67],"HIV-1-suppressing":[69,82],"proliferation":[73,107,166],"cells,":[76],"clonal":[85,141,184],"expansion":[86,142,185],"dynamics":[87],"by":[94],"measuring":[95],"frequency":[97],"harboring":[100],"inducible":[101],"upon":[103,146],"ex":[104,170],"vivo":[105],"CD3/CD28-induced":[106,147],"with":[108],"without":[110],"agents.Results:":[113],"We":[114,149],"identify":[115],"a":[116,176],"JAK1":[117],"inhibitor,":[118],"filgotinib,":[119],"suppresses":[121,139,165],"splicing,":[124],"HIV-1-driven":[125],"aberrant":[126,158],"transcription":[129],"through":[130],"modulation":[131],"splicing":[134],"machinery.We":[135],"found":[136,162],"that":[137,163],"filgotinib":[138,164],"proliferation.Conclusions:":[148],"identified":[150],"mechanism":[152],"filgotinib-induced":[154],"suppression":[155],"HIV-1-induced":[157],"transcription.We":[161],"vivo.HIV-1":[171],"serve":[174],"as":[175],"new":[177],"class":[178],"therapeutic":[180],"disrupt":[183],"cells.PP":[188],"5.7.14":[189]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2020-07-16T00:00:00"}